Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk's Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply.
U.S. regulators are allowing imports of additional supplies of a cancer drug from China amid a nationwide shortage that has forced doctors to ration care, putting patients' lives at risk.
Novo Nordisk A/S's weight-loss medications are under investigation by the European Union’s drugs regulator after a small number of reports of suicidal risks were referred to the watchdog.